Uterine Immunity and Microbiota: A Shifting Paradigm
نویسندگان
چکیده
منابع مشابه
Palliative care--a shifting paradigm.
n engl j med 363;8 nejm.org august 19, 2010 781 Attia P, Phan GQ, Maker AV, et al. Autoimmunity correlates 4. with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol 2005;23:6043-53. Schwartzentruber DJ, Lawson D, Richards J, et al. A phase III 5. multi-institutional randomized study of immunization with the gp100:209-217(210M)...
متن کاملShifting the Parallel Programming Paradigm
Multicore computer architectures are now the standard for desktop computers, high-end servers and personal laptops. Due to the multicore shift in computer architecture, software engineers must write multithreaded programs to harness the resources of these parallel machines. Unfortunately, today’s parallel programming techniques are difficult to reason about, highly error-prone and challenging t...
متن کاملImmunity, gut microbiota and infection
Recurrent infections are very common in children and a major challenge for pediatricians. They affect the children’s quality of life, cause absences from school and lost parental working days, and repeated medical examinations, hospital admissions as well as antibiotic therapies lead to high costs for society. Given their prevalence and clinical importance, various prevention strategies have be...
متن کاملHypertension and chronotherapy: shifting the treatment paradigm.
The treatment of diseases has been based on the concept of homeostasis and has not incorporated an understanding of biologic rhythms and their underlying mechanisms. Biologic rhythms are implicated in cardiovascular events. Failure to recognize the circadian decline in blood pressure may result in iatrogenic chronopathological events, including anterior ischemic optic neuropathy and cerebrovasc...
متن کاملParadigm Shift or Shifting Paradigm for Type 1 Diabetes
The age of onset of type 1A diabetes is now immunologically predictable (1). Either because of a lack of sufficient understanding of the pathogenesis of type 1A (immune-mediated) diabetes or a lack of effective therapeutics directed at relevant pathogenic pathways (or both), we cannot yet prevent this disease (2). The article by Liu et al. (3) in this issue of Diabetes addresses both issues in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Immunology
سال: 2019
ISSN: 1664-3224
DOI: 10.3389/fimmu.2019.02387